<li>agrimony<p>agrimony increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>american ginseng<p>american ginseng increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>amitriptyline<p>amitriptyline increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>amobarbital<p>amobarbital will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>amoxapine<p>amoxapine increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>anamu<p>anamu increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>aprepitant<p>aprepitant will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>armodafinil<p>armodafinil will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>artemether/lumefantrine<p>artemether/lumefantrine will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>atazanavir<p>atazanavir will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>bendroflumethiazide<p>bendroflumethiazide decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>bosentan<p>bosentan will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>budesonide<p>budesonide will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>budesonide decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>butabarbital<p>butabarbital will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>butalbital<p>butalbital will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>chlorothiazide<p>chlorothiazide decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>chlorthalidone<p>chlorthalidone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>chromium<p>chromium increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>clobetasone<p>clobetasone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>clobetasone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>clomipramine<p>clomipramine increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>clonidine<p>clonidine decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.<span><br><br></span>clonidine, pioglitazone. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.</p></li><li>conivaptan<p>conivaptan will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>cornsilk<p>cornsilk increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).</p></li><li>cortisone<p>cortisone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>cortisone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>cyclopenthiazide<p>cyclopenthiazide decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>cyclosporine<p>cyclosporine will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>damiana<p>damiana decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>danazol<p>danazol increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>darifenacin<p>darifenacin will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>darunavir<p>darunavir will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>dasatinib<p>dasatinib will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>deferasirox<p>deferasirox will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>deflazacort<p>deflazacort decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>delavirdine<p>delavirdine will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>desipramine<p>desipramine increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>devil's claw<p>devil's claw increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>dexamethasone<p>dexamethasone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>dexamethasone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>dhea, herbal<p>dhea, herbal will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>diltiazem<p>diltiazem will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>dosulepin<p>dosulepin increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>doxepin<p>doxepin increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>dronedarone<p>dronedarone will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>efavirenz<p>efavirenz will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>elderberry<p>elderberry increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).</p></li><li>eslicarbazepine acetate<p>eslicarbazepine acetate will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>ethotoin<p>ethotoin will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>etravirine<p>etravirine will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>eucalyptus<p>eucalyptus will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>eucalyptus increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>fluconazole<p>fluconazole will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>fludrocortisone<p>fludrocortisone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>fludrocortisone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>fluoxymesterone<p>fluoxymesterone increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>fluvoxamine<p>fluvoxamine will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>fo-ti<p>fo-ti increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>forskolin<p>forskolin increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Colenol, a compound found in Coleus root, may stimulate insulin release.</p></li><li>fosamprenavir<p>fosamprenavir will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>fosphenytoin<p>fosphenytoin will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>gotu kola<p>gotu kola increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. (Theoretical interaction).</p></li><li>grapefruit<p>grapefruit will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>griseofulvin<p>griseofulvin will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>guanabenz<p>guanabenz decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.<span><br><br></span>guanabenz, pioglitazone. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.</p></li><li>guanfacine<p>guanfacine decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.<span><br><br></span>guanfacine, pioglitazone. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.</p></li><li>gymnema<p>gymnema increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>hexobarbital<p>hexobarbital will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>horse chestnut seed<p>horse chestnut seed increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>hydrochlorothiazide<p>hydrochlorothiazide decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>hydrocortisone<p>hydrocortisone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>hydrocortisone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>imipramine<p>imipramine increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>indapamide<p>indapamide decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>indinavir<p>indinavir will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>isoniazid<p>isoniazid will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>isoniazid decreases effects of pioglitazone by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>juniper<p>juniper increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).</p></li><li>lofepramine<p>lofepramine increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>lumefantrine<p>lumefantrine will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>lycopus<p>lycopus increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).</p></li><li>maitake<p>maitake increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).</p></li><li>maprotiline<p>maprotiline increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>marijuana<p>marijuana will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>mephobarbital<p>mephobarbital will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>mesterolone<p>mesterolone increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>mestranol<p>pioglitazone decreases levels of mestranol by unknown mechanism. Minor/Significance Unknown.</p></li><li>methyclothiazide<p>methyclothiazide decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>methylprednisolone<p>methylprednisolone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>methylprednisolone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>methyltestosterone<p>methyltestosterone increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>metolazone<p>metolazone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>metronidazole<p>metronidazole will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>mianserin<p>mianserin increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>mibefradil<p>mibefradil will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>miconazole vaginal<p>miconazole vaginal will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>modafinil<p>modafinil will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>nelfinavir<p>nelfinavir will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>nettle<p>nettle increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. (Theoretical interaction).</p></li><li>nevirapine<p>nevirapine will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>nifedipine<p>nifedipine will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>nilotinib<p>nilotinib will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>nortriptyline<p>nortriptyline increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>ofloxacin<p>ofloxacin, pioglitazone. Mechanism: unspecified interaction mechanism. Minor/Significance Unknown. Potential dysglycemia.</p></li><li>oxandrolone<p>oxandrolone increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>oxcarbazepine<p>oxcarbazepine will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>oxiconazole<p>oxiconazole will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>oxymetholone<p>oxymetholone increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>pegvisomant<p>pegvisomant increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>pentobarbital<p>pentobarbital will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>phenobarbital<p>phenobarbital will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>phenytoin<p>phenytoin will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>posaconazole<p>posaconazole will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>potassium acid phosphate<p>potassium acid phosphate increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.</p></li><li>potassium chloride<p>potassium chloride increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.</p></li><li>potassium citrate<p>potassium citrate increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.</p></li><li>prednisolone<p>prednisolone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>prednisolone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>prednisone<p>prednisone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>prednisone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>primidone<p>primidone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>protriptyline<p>protriptyline increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>quinupristin/dalfopristin<p>quinupristin/dalfopristin will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>rifapentine<p>rifapentine will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>ritonavir<p>ritonavir will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>rufinamide<p>rufinamide will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>sage<p>sage increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>secobarbital<p>secobarbital will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>sitaxentan<p>sitaxentan will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>stevia<p>stevia increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>telithromycin<p>telithromycin will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>testosterone<p>testosterone increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>testosterone buccal system<p>testosterone buccal system increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>testosterone topical<p>testosterone topical increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>tongkat ali<p>tongkat ali increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Risk of hypoglycemia.</p></li><li>topiramate<p>topiramate will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>trazodone<p>trazodone increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>triamcinolone<p>triamcinolone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.<span><br><br></span>triamcinolone decreases effects of pioglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>trimipramine<p>trimipramine increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>troglitazone<p>troglitazone will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>troleandomycin<p>troleandomycin will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>vanadium<p>vanadium increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>verapamil<p>verapamil will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>voriconazole<p>voriconazole will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>zafirlukast<p>zafirlukast will increase the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li>